Brooks Introduces Azenta Life Sciences To Advance Innovative Sample Solutions

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

$2 Billion Expansion By J&J in North Carolina Facility

Johnson & Johnson on August 21, 2025, went on...

Pharma Sector Reactions to US-EU Trade Framework Deal

The United States and the EU have, on August...

Chinese Pharmaceutical Firms Turn to Local Reagent Suppliers

The Chinese pharmaceutical firms are increasingly looking out for...

Trump Executive Order to Cover 26 Drugs Critical to Health

US president Donald Trump has gone on to direct...

Brooks Automation, Inc. announces Brooks Life Sciences Services and Products businesses will be rebranded under the creation of a new identity – Azenta Life Sciences. Azenta will bring together our existing portfolio of life sciences products and services to deliver integrated enterprise-wide sample exploration and management solutions.

“We are excited to announce the creation of Azenta as it reinforces our commitment to helping customers reach new heights in their pursuit of scientific progress,” said Steve Schwartz, Brooks’ President and CEO. “Azenta embodies our industry-leading expertise which will be seamlessly offered across an integrated portfolio to help drive innovation, and accelerate discovery, development and delivery of critical new therapies.”

The life sciences industry will benefit from the Azenta portfolio and vision with the integration of industry-leading capabilities within automated ultra-cold sample storage and sample repository solutions, sample sourcing and genomic services, data management and informatics, and consumables and instruments.

“Our customers have seen the unrelenting demands for a partner that can protect their critical samples in research and clinical trials along with offering deep expertise, speed, integrity and trust for unparalleled sample exploration and management solutions,” said Linda De Jesus, Senior Vice President and Chief Commercial Officer. “Our new strategic focus with Azenta will enable our company to better serve our customers with scale, end-to-end solutions and robust capabilities that will drive innovation and growth with greater speed and precision.”

Azenta has operations across North America, Europe and Asia, and serves customers worldwide. Over the coming months, legacy brands will be consolidated under the Azenta brand.

About Brooks Automation
Brooks operates two global, market-leading businesses, Life Sciences and Semiconductor Solutions, each with its own distinct area of focus and expertise. The Life Sciences business, to be operated under the new Azenta brand, provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry’s top pharmaceutical, biotech, academic and healthcare institutions globally. On September 20, 2021, the Company announced the pending sale to Thomas H. Lee Partners of its Semiconductor Solutions Group business, which provides industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world’s leading semiconductor chip makers and equipment manufacturers as well as collaborative robotics and automation capabilities for multi-market applications. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia.

Latest stories

Related stories

$2 Billion Expansion By J&J in North Carolina Facility

Johnson & Johnson on August 21, 2025, went on...

Pharma Sector Reactions to US-EU Trade Framework Deal

The United States and the EU have, on August...

Chinese Pharmaceutical Firms Turn to Local Reagent Suppliers

The Chinese pharmaceutical firms are increasingly looking out for...

Trump Executive Order to Cover 26 Drugs Critical to Health

US president Donald Trump has gone on to direct...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back